CardiovascularLevosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery†
Under an Elsevier user license
open archive
Keywords
heart, coronary artery bypass
heart, inotropism
heart, ischaemia
surgery, cardiovascular
Cited by (0)
- †
Trial registration: clinicaltrials.gov identifier: nCT00610350.
- ‡
Declaration of interest. L.T., F.G., and M.S. have sat on advisory boards for levosimendan on behalf of Orion, the manufacturer, and Abbott, the distributor. They have also received honoraria for chairing/speaking at satellite symposia.
Copyright © 2009 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.